Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

The head of drugmaker Eli Lilly, which sells the popular weight ... right mechanism” to bolster U.S. drug manufacturing, Lilly Chief Executive David Ricks said on a conference call with analysts ...

INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that ... Ricks, Lilly's chair and CEO. "With these changes, we will create ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

USPS said its controllable loss was $848 million, up from $317 million in the same quarter last year as mail volume continues ...

Eli Lilly announced a strategic executive shuffle aimed at boosting its U.S. and global operations, especially in ...

Indianapolis: Eli Lilly and Company has announced executive leadership transitions affecting its ... Ricks, Lilly's chair and CEO. "With these changes, we will create the additional focus we need to ...

"With these changes, we will create the additional ... open-label trial in dry (non-neovascular)... Eli Lilly and Company today announced executive leadership transitions that will further enhance ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...